An unwelcome merger deal for the Honeycomb Investment Trust
A deal to buy its own manager makes this high-yielding debt fund less appealing, says David Stevenson
The Honeycomb Investment Trust (LSE: HONY) is a fund which invests in debt. It came through the pandemic with an excellent record in terms of defaults. Until recently it has provided investors with an 8%-plus dividend yield, backed by a broad portfolio of debt: everything from small business loans to consumer credit. If a fund promises more than 7.5% a year in dividends, I make it a rule to scrutinise it closely, but Honeycomb passed my test.
However, last month it announced something unusual.
Honeycomb is run by fund manager Pollen Street Capital, a private debt specialist. While there was some controversy surrounding its involvement in a lending fund called P2P Global Investments, Pollen Street has a good record and has appealed to adventurous types looking for yield.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
An unusual reverse merger
But Pollen Street clearly felt something was missing. Honeycomb traded on a 6% discount to net asset value, which made raising extra capital harder, while Pollen Street had, by December, amassed a pipeline of £1.5bn in loans. How to square the circle of an asset manager hungry to grow its balance sheet with a stockmarket unwilling to put more money into the main listed fund? The answer came last month. Honeycomb will acquire Pollen Street in an all-share deal that values the investment manager at around £285m. More than half of Honeycomb’s shareholder register has backed the deal, which is due to complete next quarter.
Matt Hose of investment bank Jefferies notes that this £285m price tag represents a valuation equivalent to about 10% of Pollen Street’s £3bn assets under management (AUM), although if that £3bn includes Honeycomb’s existing £600m-odd of assets, which it seems to, it’s more like 12%. That falls to 6%-8% based on the group’s medium-term aim to grow AUM to £4bn-£5bn. Hose thinks this represents a “broadly fair” valuation; in my view, it seems a tad expensive.
A very different company
The new entity will look and feel very different, in effect becoming an operating business with a big balance sheet attached. Moreover, Hose notes that the dividend will be cut from today’s 80p to 63p in 2022 and 64p in 2023. Suddenly wealth managers and private investors who thought they were investing in a pure-play alternative-income dividend vehicle are in effect forced into an operating business with much greater risk, though arguably more upside. Unfortunately there is no tender to take out investors who might be unhappy with the deal – I would strongly suggest private investors lobby for one.
Here’s what I’d rather see
A handful of funds either wholly own their fund manager or a stake in it (Lindsell Train is a classic example). Over the next year I suspect we’ll see more examples of managers reversing into their funds in this sector – Hose notes that some are struggling to grow, and so moving the fund manager into the fund vehicle offers the “potential to capture current high market valuations” for asset managers. But while I can see how in the equities sector adding the fund manager stake adds upside leverage, in the alternatives sector most investors want simpler, less risky, income-based options. Adding the fund manager just increases risk and gets in the way of that income focus.
A preferable alternative to reverse mergers would be more merger and acquisition deals. If public markets won’t fund growth, and thus effectively undervalue alternative assets, what’s to stop private equity firms from snapping them up? We’ve already seen one fund, GCP, taken over in this way. I think we’ll see a sharp rise in such activity in two sectors in particular – renewables and energy infrastructure, plus real estate investment trusts – as the fund-raising pipeline for many listed funds closes due to market volatility.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
David Prosser is a regular MoneyWeek columnist, writing on small business and entrepreneurship, as well as pensions and other forms of tax-efficient savings and investments. David has been a financial journalist for almost 30 years, specialising initially in personal finance, and then in broader business coverage. He has worked for national newspaper groups including The Financial Times, The Guardian and Observer, Express Newspapers and, most recently, The Independent, where he served for more than three years as business editor.
-
How hitting the ‘broadest shoulders’ in the Autumn Budget could end up costing the Treasury billions
The government has promised that tax rises in next week’s Budget will hit those with the ‘broadest shoulders’ – what could this mean for the ultra-wealthy?
By Marc Shoffman Published
-
Is property becoming uninsurable?
Climate change and other issues are leading property insurers to recalculate risk and raise premiums. But will that make policies unaffordable? And if so, what then?
By Simon Wilson Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Is Brevan Howard Macro a good investment?
Holding Brevan Howard, a world-leading vehicle through an investment trust, offers diversification on the cheap
By Rupert Hargreaves Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Is China an undervalued market?
Most funds remain wary of China amid slowing growth. Have they got it wrong?
By Max King Published
-
A fairer deal for investment trusts
New rules on how investment trusts report costs should ditch the idea that investors only need to look at one number
By Cris Sholto Heaton Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published